Related Experiment Video
Updated: Aug 5, 2026
07:49
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
The Evolving Role of Long-Acting Injectable Antipsychotics
Jose M Rubio1,2,3
1Northwell, New Hyde Park, NY.
Focus (American Psychiatric Publishing)
|August 1, 2026
Summary
Long-acting injectable antipsychotics (LAIs) are vital for preventing schizophrenia relapse, especially in early stages. Proactive use of LAIs improves patient adherence and outcomes, reducing hospitalizations and enhancing quality of life.
Area of Science:
- Psychiatry
- Pharmacology
- Mental Health
Background:
- Continuous antipsychotic treatment is essential for schizophrenia relapse prevention.
- Long-acting injectable antipsychotics (LAIs) offer consistent medication delivery.
- Early intervention in schizophrenia is critical to prevent irreversible consequences of relapse.
Purpose of the Study:
- To review literature comparing long-acting injectable antipsychotics (LAIs) with oral formulations for schizophrenia management.
- To highlight the evolving role of LAIs as proactive interventions, particularly in early-stage schizophrenia.
- To emphasize the importance of effective communication regarding LAI benefits and practicalities.
Main Methods:
- Literature review comparing LAIs and oral antipsychotics.
- Analysis of outcomes including relapse prevention, recovery, and mortality.
- Examination of clinical and practical considerations for LAI implementation.
Main Results:
- LAIs ensure consistent medication delivery, crucial for relapse prevention in schizophrenia.
- LAIs are increasingly recognized as essential tools for early treatment stages.
- Effective communication and family engagement enhance patient adherence and treatment outcomes.
Conclusions:
- LAIs are valuable components of schizophrenia management, particularly in early phases.
- Strategic implementation of LAIs can optimize patient adherence and improve quality of life.
- Clinicians should proactively discuss LAI benefits, practicalities, and tailored treatment options with patients and families.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...